Recent studies have shown that PRMT1 acts as an epigenetic transcription regulator by activating gene transcription, thereby regulating the occurrence and development of a variety of tumors, including breast cancer, hepatocellular carcinoma, and colorectal cancer [20–23]. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.